INSR and metabolic dysfunction-associated steatotic liver disease: The IRS-1 (Gly972Arg) polymorphism also affects insulin receptor activity, predisposing to hepatocyte injury and decreased hepatic insulin signalling in NAFLD individuals (Dongiovanni et al., 2010).